Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2009; 15(19): 2381-2388
Published online May 21, 2009. doi: 10.3748/wjg.15.2381
Published online May 21, 2009. doi: 10.3748/wjg.15.2381
Table 2 Demonstration of antibodies against HP-NAP in serum from H pylori-infected patients by ELISA n (%)
| Patient group | Positivity for HP-NAP antibodies | Negativity for HP-NAP antibodies | Absorbance (mean ± 2SD) (cut-off value 0.78) | Range |
| Gastric cancer group (n = 43) | 42 (97.7) | 1 (2.3) | 1.01 ± 0.24 | 0.748-1.269 |
| Peptic ulcer group (n = 28) | 26 (92.8) | 2 (7.1) | 0.98 ± 0.32 | 0.771-1.265 |
| Chronic gastritis group (n = 28) | 24 (85.7) | 4 (14.3) | 0.89 ± 0.14 | 0.711-1.122 |
| Healthy persons (HP-IgG positive n = 47) | 13 (27.7) | 34 (72.3) | 0.65 ± 0.18 | 0.451-0.948 |
-
Citation: Long M, Luo J, Li Y, Zeng FY, Li M. Detection and evaluation of antibodies against neutrophil-activating protein of
Helicobacter pylori in patients with gastric cancer. World J Gastroenterol 2009; 15(19): 2381-2388 - URL: https://www.wjgnet.com/1007-9327/full/v15/i19/2381.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2381